Park, Jong Beom
Kim, Kiyoung
Kang, Min Seok
Kim, Eung Suk
Yu, Seung-Young
Funding for this research was provided by:
Bayer (20306)
Article History
Received: 7 March 2023
Accepted: 12 June 2023
First Online: 12 July 2023
Declarations
:
: This study was approved by the Institutional Review Board (IRB) of Kyung Hee University Hospital (2017-12-092). This study was conducted in accordance with the tenets of the Declaration of Helsinki. All patients provided written informed consent to participate in this study, which was obtained from all participants in a manner consistent with the Declaration of Helsinki. No one received compensation or was offered any incentive for participating in this study. The trial was registered with the Clinical Research Information Service (CRIS), which joined the WHO International Clinical Trials Registry Platform (ICTRP) (Registration number: KCT0007375, Date of first trial registration: 10/06/2022).
: Not applicable.
: Disclosure of potential conflicts of interest: Seung-Young Yu received research support from Allergan, Bayer, Carl Zeiss Meditec, Heidelberg Engineering, and Novartis. Jong Beom Park, Kiyoung Kim, Min Seok Kang and Eung Suk Kim have no conflicts of interest to declare.